These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10227010)

  • 1. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy.
    Iwamoto I; Kosha S; Noguchi S; Murakami M; Fujino T; Douchi T; Nagata Y
    Maturitas; 1999 Jan; 31(2):161-4. PubMed ID: 10227010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2000; 5(6):546-51. PubMed ID: 11180916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.
    Komulainen M; Tuppurainen MT; Kröger H; Heikkinen AM; Puntila E; Alhava E; Honkanen R; Saarikoski S
    Osteoporos Int; 1997; 7(2):126-32. PubMed ID: 9166392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Jurvelin J; Saarikoski S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K; Fukasawa H; Fujigaki Y; Hishida A
    Am J Kidney Dis; 2004 Jan; 43(1):53-60. PubMed ID: 14712427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of vitamin D3 on inhibitory effect of vitamin K2 on bone loss in ovariectomized rats].
    Hara K; Akiyama Y; Tomiuga T; Kobayashi M; Nakamura T; Tajima T
    Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):101-9. PubMed ID: 7927067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
    Gorai I; Chaki O; Taguchi Y; Nakayama M; Osada H; Suzuki N; Katagiri N; Misu Y; Minaguchi H
    Calcif Tissue Int; 1999 Jul; 65(1):16-22. PubMed ID: 10369728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The preventive effect of estrogen and vitamin D on postmenopausal bone loss].
    Soda M; Mizunuma H; Honjo S; Okano H; Ibuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):106-12. PubMed ID: 8381451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
    Shiraki M; Shiraki Y; Aoki C; Miura M
    J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis prevention clinical study program.
    Delmas P; Gimona A
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
    Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss.
    Mizunuma H; Shiraki M; Shintani M; Gorai I; Makita K; Itoga S; Mochizuki Y; Mogi H; Iwaoki Y; Kosha S; Yasui T; Ishihara O; Kurabayashi T; Kasuga Y; Hayashi K
    J Bone Miner Metab; 2006; 24(1):11-5. PubMed ID: 16369892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
    Shiomi S; Nishiguchi S; Kubo S; Tamori A; Habu D; Takeda T; Ochi H
    Am J Gastroenterol; 2002 Apr; 97(4):978-81. PubMed ID: 12003435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide.
    Somekawa Y; Chigughi M; Harada M; Ishibashi T
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2700-4. PubMed ID: 10443663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.